Abstract:Our objective was to develop an array of alpha(7)-selective nicotinic cholinergic receptor (nAChR)-based imaging agents for PET and SPECT. Methods: (2'R)-N-C-11-Methyl-N-(phenylmethyl)-spiro[1-azabicyclo[2.2.2]octane-3,2'(3'H)-furo[2,3-b]pyridin]-5'-amine 1 was synthesized by reaction of the corresponding desmethyl precursor with C-11-CO2 and reduction. N-(R)-1-Aza-bicyclo[2.2.2]oct-3-yl-4-C-11-methylsulfanyl-benzamide 2 was synthesized by reduction of the corresponding disulfide precursor and reaction with C-11-iodomethane. N-(R)-1-Aza-bicyclo[2.2.2]oct-3-yl-4-'251-iodo-benzamide 3 was synthesized by halogen exchange of the corresponding bromide. (2'R)-5'-(2-I-125-iodo-3-furanyl)spiro[1-azabicyclo[2.2.2] octane]-3,2'(3'H)-furo[2,3-b]pyridine 4 was synthesized by the chloramine-T method. Kinetic biodistribution studies were done in male CD-1 mice by tail vein injection of 3.7 MBq (100 muCi) of the C-11-labeled radiotracer or 0.67 MBq (2 muCi) of the I-125-labeled radiotracer followed by brain dissection and tissue counting. Receptor blockade was determined by pretreatment of the mice with an excess of either unlabeled precursor or nicotine. Results: We synthesized 4 radiolabeled, moderate- to high-affinity, mu(7)-nAChR-based ligands. The compounds were a series of quinuclidine derivatives with an inhibition constant (K-i) < 6 nmol/L (33 pmol/L for 4) for alpha(7)-nAChR and selectivities of alpha(7)/alpha(4)beta(2) subtypes of greater than or equal to 14,000. All of the compounds were produced in adequate radiochemical yield and specific radioactivity (>74 GBq/mumol [2,000 Ci/mmol]). No site selectivity or receptor blockade was shown for 1 and 2 (0.91 +/- 0.05 and 0.14 +/- 0.03 %ID/g [percentage injected dose per gram] in the hippocampus [target tissue], respectively). Compound 3 showed low hippocampal uptake (0.25 +/- 0.05 %ID/g) but prolonged retention within that structure. Pretreatment with nicotine decreased its uptake by up to 50% in the hippocampus. Similar reductions were also observed within the cerebellum (nontarget tissue). Compound 4 showed hippocampal uptake of 2.41 +/- 0.03 %ID/g and target-to-nontarget uptake ratios of up to 2. Pretreatment of animals with unlabeled 4 resulted in a decrease of hippocampal uptake to 60% of its preblockade value without a corresponding decrease in cerebellar uptake. Conclusion: With further structural optimization, selective imaging of a7-nAChR may be possible.

Synthesis and Biological Evaluation of 9-Fluorenone Derivatives for SPECT Imaging of Α7-Nicotinic Acetylcholine Receptor

Radioiodinated 9-Fluorenone Derivatives for Imaging Α7-Nicotinic Acetylcholine Receptors.

Synthesis and biodistribution of radiolabeled alpha 7 nicotinic acetylcholine receptor ligands.

Design, Synthesis and Biological Evaluation of 1,4-Diazobicylco[3.2.2]nonane Derivatives As Α7-Nicotinic Acetylcholine Receptor PET/CT Imaging Agents and Agonists for Alzheimer's Disease.

Radiochemical synthesis and in vivo evaluation of [18F]AZ11637326: an agonist probe for the α7 nicotinic acetylcholine receptor.

Synthesis and structure-affinity relationships of selective high-affinity 5-HT(4) receptor antagonists: application to the design of new potential single photon emission computed tomography tracers

Design and Synthesis of New Agents for Neuronal Nicotinic Acetylcholine Receptor (nachrs) Imaging.

Radiosynthesis and In-Vivo Evaluation of [125I]IBT

Synthesis and Evaluation of Novel N-Fluoropyridyl Derivatives of Tropane As Potential Pet Imaging Agents for the Dopamine Transporter

Study on Chiba-1001 As A Novel Radioligand for Alpha 7 Nicotinic Acetylcholine Receptors

Correction to "development of 11C-Labeled ASEM Analogues for Detection of Neuronal Nicotinic Acetylcholine Receptors (Α7-Nachr)".

Synthesis and evaluation of a (18) F-labeled 4-phenylpiperidine-4-carbonitrile radioligand for σ1 receptor imaging.

Pharmacological Characterization of [125I]CHIBA-1006 Binding, a New Radioligand for Α7 Nicotinic Acetylcholine Receptors, to Rat Brain Membranes

Synthesis and Biological Evaluation of 18F Labeled Fluoro-Oligo-ethoxylated 4-Benzylpiperazine Derivatives for Sigma-1 Receptor Imaging

Synthesis and Characterization of [18F]JNJ-46356479 as the First 18F-Labeled PET Imaging Ligand for Metabotropic Glutamate Receptor 2

Synthesis and Preliminary Studies of a Novel Negative Allosteric Modulator, 7-((2,5-Dioxopyrrolidin-1-yl)methyl)-4-(2-fluoro-4-[11C]methoxyphenyl) quinoline-2-carboxamide, for Imaging of Metabotropic Glutamate Receptor 2

Design, synthesis, and biological evaluation of multiple F-18 S1PR1 radiotracers in rodent and nonhuman primate

Synthesis, pharmacology and preclinical evaluation of 11C-labeled 1,3-dihydro-2H-benzo[d]imidazole-2-ones for imaging γ8-dependent transmembrane AMPA receptor regulatory protein

Neural Nachrs PET Imaging Probes

Exploration of Sulfur-Containing Analogues for Imaging Vesicular Acetylcholine Transporter in the Brain

Synthesis and evaluation of two new candidate high-affinity full agonist PET radioligands for imaging 5-HT1B receptors